As expected, urinary RBP/creatinine ratio in NAFLD patients was higher than that in the control group (median, 0.32 mg/g vs 0.21 mg/g, P < 0.001). This evidence concerns the gene RBP4 and metabolic dysfunction-associated steatotic liver disease.